Retrospective analysis of COVID-19 clinical and laboratory data: Constructing a multivariable model across different

Mahdieh Shokrollahi Barough1, Mohammad Darzi2, Masoud Yunesian3

  • 1Department of Immunology, School of Medicine Iran University of Medical Sciences, Tehran, Iran; Immunology research center institute of immunology and infectious diseases Iran University of Medical Sciences, Tehran, Iran; ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran.

Insights

COVID-19 mortality is higher in males and significantly predicted by age over 55. Kidney disease is the deadliest comorbidity, while CT scans have no predictive value for death.

Area of Science:

  • Medical research
  • Epidemiology
  • Public Health

Background:

  • Understanding COVID-19 pathogenesis requires homogeneous studies on disease mechanisms.
  • Identifying clinical and laboratory predictors is crucial for prognosis and treatment.
  • This study aimed to predict COVID-19 mortality using comorbidities and laboratory metrics.

Purpose of the Study:

  • To analyze comorbidities and laboratory parameters for predicting COVID-19 mortality.
  • To identify key predictors of mortality in a homogeneous patient cohort.
  • To inform effective treatment strategies and improve patient prognosis.

Main Methods:

  • Retrospective cohort study of 7500 COVID-19 patients (2022-2022).
  • Collected and analyzed clinical, laboratory, and comorbidity data.
  • Employed machine learning for feature identification and predictive scoring.

Main Results:

  • Male COVID-19 patients had higher mortality rates (19.3%) than females (17%).
  • Cancer and Alzheimer's were common comorbidities linked to long-term hospitalization.
  • Kidney disease (KD) was the most lethal comorbidity (45% mortality); age >55 was the strongest mortality predictor.
  • WBC, Cr, CRP, ALP, and VBG-HCO3 were significant predictors across comorbidities; CT scan scores were not predictive.

Conclusions:

  • Age is a critical factor in COVID-19 prognosis, especially for elderly patients.
  • Kidney disease significantly impacts COVID-19 mortality outcomes.
  • Predictive models incorporating comorbidities and lab data can guide clinical management.
Abstract